Pharmacological inhibition with the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; generally known as FRAP-relevant protein (FRP1)) has emerged for a promising approach for most cancers treatment method that exploits synthetic lethal interactions with proteins involved in DNA harm maintenance, overcomes resistance to other therapies and boosts antitumour ... https://ovinia222nyi5.get-blogging.com/profile